TrialDiabetes technology & therapeutics2018

Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes.

Philip Home et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.